Symantec Corporation Upgraded by BMO Capital Markets to Out Perform; Procter & Gamble is Dow’s Top Performing Stock Monday

Follow this company

Companies Mentioned

03/25/2014 [ACCESSWIRE]

The Procter & Gamble Company (NYSE: PG) – For an in-depth report on The Procter & Gamble Company follow:

PG shares closed up a modest 1.82% on Monday with about 11.2 million shares traded. The stock was one of the most active stocks on the NYSE. The stock was the Dow's best-performing stock of the day despite no significant news released.

Symantec Corporation (NASDAQ: SYMC) - For an in-depth report on Symantec Corporation follow:

Shares of Symantec Corporation closed up 4.89% on about 22.6 million shares traded. The stock was one of the most active stocks on the NASDAQ and had more than double trading volume than average on Monday. The stock was upgraded by BMO Capital Markets from Market Perform to Out Perform.

Growlife, Inc. (OTCBB: PHOT) - For an in-depth report on Growlife, Inc. follow:

PHOT shares closed down 13.92% on about 52.7 million shares traded. The stock was one of the biggest decliners in the OTCBB market. Last Friday the company announced that  together with Organic Growth International, LLC ("OGI"), its joint venture with CANX USA, LLC, extended the date for completion of due diligence and closing the transaction with RXNB Inc. ("RXNB") to April 4, 2014.   Under the agreement, GrowLife will sell and distribute RXNB proprietary technologies globally, and share profits related to technology licensing, subject to the approval of the GrowLife Board of Directors.  GrowLife currently has a 45% ownership interest in OGI, with conditions under which it can gain majority interest. 

22nd Century Group, Inc. (NYSE: XXII) - For an in-depth report on 22nd Century Group, Inc. follow:

Shares of XXII closed down nearly 24% on Monday with about 3 million shares traded. The stock was one of the biggest decliners on the NYSE despite any significant news being released from the company. It was earlier this month that the company received approval to list its common stock on the NYSE MKT. Trading on the NYSE MKT commenced on Tuesday, March 11, 2014. 22nd Century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and plant breeding.


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures. 


Leave a comment...

Your Name